For primary prevention of cardiovascular disease, NICE recommends offering atorvastatin 20 mg to people with a 10‑year QRISK3 score of 10% or more NICE NG238.
Before initiating statin treatment, discuss the benefits of lifestyle changes and optimise management of all modifiable risk factors NICE NG238.
If lifestyle changes are ineffective or inappropriate, then statin treatment should be offered NICE NG238.
People should be informed that any statin at any dose reduces CVD risk NICE NG238.
In people aged 85 and older, consider treatment with atorvastatin 20 mg, taking into account individual factors that may make treatment inappropriate NICE NG238.
Statins are contraindicated in pregnancy and should be stopped if pregnancy is possible or planned, and not restarted until breastfeeding is finished NICE NG238.